| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| FLG-AS1 |
|
FLG antisense RNA 1
|
|
|
0.700 |
0.538 |
| RTEL1-TNFRSF6B |
|
RTEL1-TNFRSF6B readthrough (NMD candidate)
|
|
|
0.682 |
0.385 |
| LINC00299 |
Q6ZSB3
|
long intergenic non-protein coding RNA 299
|
|
|
0.743 |
0.346 |
| TH2LCRR |
|
T helper type 2 locus control region associated RNA
|
|
|
0.751 |
0.385 |
| ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
| SOCAR |
|
serous ovarian cancer associated RNA
|
|
|
0.821 |
0.231 |
| LINC01149 |
|
long intergenic non-protein coding RNA 1149
|
|
|
0.792 |
0.346 |
| STX18-AS1 |
|
STX18 antisense RNA 1 (head to head)
|
|
|
0.890 |
0.154 |
| NCF4-AS1 |
|
NCF4 antisense RNA 1
|
|
|
1.000 |
0.038 |
| DUBR |
|
DPPA2 upstream binding RNA
|
|
|
0.861 |
0.154 |
| FAM205C |
A6NFA0
|
family with sequence similarity 205 member C
|
|
|
1.000 |
0.077 |
| MIR6891 |
|
microRNA 6891
|
|
|
1.000 |
|
| LINC02121 |
|
long intergenic non-protein coding RNA 2121
|
|
|
1.000 |
0.077 |
| DHFRP2 |
|
dihydrofolate reductase pseudogene 2
|
|
|
1.000 |
0.038 |
| SDR42E1P5 |
|
short chain dehydrogenase/reductase family 42E, member 1 pseudogene 5
|
|
|
|
|
| FGFR3P1 |
|
fibroblast growth factor receptor 3 pseudogene 1
|
|
|
|
|
| LINC02579 |
|
long intergenic non-protein coding RNA 2579
|
|
|
|
|
| SELP |
P16109
|
selectin P
|
|
5.0E-32 |
0.460 |
0.769 |
| RASA2 |
Q15283
|
RAS p21 protein activator 2
|
Enzyme modulator
|
7.4E-31 |
0.579 |
0.769 |
| TTC6 |
Q86TZ1
|
tetratricopeptide repeat domain 6
|
|
1.1E-25 |
0.931 |
0.154 |